https://www.heartfailure-pathway.elicla-dev.be/en/sample-page/2022-04-13T15:07:46+02:00https://www.heartfailure-pathway.elicla-dev.be/en/test/2024-11-01T17:40:54+01:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/2024-01-24T14:57:15+01:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/2024-01-24T14:57:01+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/2024-01-24T15:36:28+01:00https://www.heartfailure-pathway.elicla-dev.be/en/home/2024-01-31T14:25:00+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/2024-11-06T14:41:58+01:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/2024-02-07T11:07:20+01:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/2025-03-11T11:30:29+01:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/the-diagnosis-of-heart-failure/2024-05-29T11:52:58+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/symptoms-of-heart-failure/2024-05-29T12:12:21+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/nt-pro-bnp/2024-11-11T18:17:48+01:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/classifications/2024-05-29T13:57:45+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/classifications/new-york-heart-association-functional-classification-the-nyha-classification/2024-05-29T13:58:51+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/classifications/classification-of-heart-failure-according-to-left-ventricular-ejection-fraction-lvef/2024-05-29T14:06:49+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/classifications/acute-versus-chronic-heart-failure/2024-05-29T14:17:58+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/the-diagnosis-of-heart-failure/causes-of-heart-failure/2024-05-31T13:25:18+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/the-diagnosis-of-heart-failure/reversible-versus-non-reversible-causes-of-heart-failure/2024-05-31T13:15:29+02:00https://www.heartfailure-pathway.elicla-dev.be/en/diagnosis/the-diagnosis-of-heart-failure/the-diagnosis-of-heart-failure/diagnostic-essay/2024-05-31T13:40:29+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/general-guidelines-always-to-be-pursued-regardless-of-the-lvef/2024-05-31T14:01:41+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/the-treatment-of-heart-failure-with-reduced-lvef-hfref-lvef-%e2%89%a4-40/2024-05-31T14:27:59+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/the-treatment-of-heart-failure-with-mildly-reduced-lvef-hfmref-lvef-41-49/2024-05-31T14:37:29+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/the-treatment-of-heart-failure-with-preserved-lvef-hfpeflvef-%e2%89%a5-50/2024-06-04T15:15:05+02:00https://www.heartfailure-pathway.elicla-dev.be/en/medicines-to-avoid-or-which-are-contraindicated/2024-06-04T13:51:25+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/2024-06-04T13:57:55+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/diuretics/2024-06-04T14:19:43+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/ace-inhibitors-and-arb-angiotensin-ii-receptor-antagonists-sartans/2024-06-05T11:52:22+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/beta-blockers/2024-09-10T11:36:47+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/arni-angiotensin-receptor-neprilysin-inhibitor-valsartan-sacubutril-entresto/2024-06-05T13:25:22+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/therapy-with-implantable-devices-icd-crt-lbba-pacing/2024-06-07T15:24:50+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/specific-cardiomyopathies/2024-06-12T11:58:28+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/advanced-heart-failure-lvad-and-heart-transplantation/2024-09-24T13:50:48+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/mineralocorticoid-receptor-antagonists-mra-aldosterone-blockers/2024-06-12T13:33:30+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/sglt2-inhibitors-gliflozines/2024-06-14T16:04:53+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/ivabradine-procoralan/2024-06-19T11:58:33+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/cedocard-isosorbide-dinitrate-and-or-hydralazine-magistral/2024-06-19T12:06:35+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/digoxine/2024-06-19T12:17:28+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/intravenous-iron/2025-06-03T14:51:34+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/medicines-for-heart-failure/peroral-potassium-binders/2024-06-19T12:58:52+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/detection-of-problems-during-the-follow-up-of-a-patient-with-heart-failure/2024-06-21T16:57:39+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/what-is-heart-failure/2024-06-25T14:03:14+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/follow-up-after-the-diagnosis-of-heart-failure-points-to-consider-as-a-patient/2024-06-25T14:41:19+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/use-of-medications-in-heart-failure/2024-06-25T15:25:49+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/diet-for-heart-failure/2024-06-26T11:43:58+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/fluid-intake-in-heart-failure/2025-05-07T14:09:05+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-and-family/living-with-heart-failure/2024-06-26T12:05:36+02:00https://www.heartfailure-pathway.elicla-dev.be/en/sponsors-en/2024-08-30T16:53:12+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/what-to-do-in-advanced-heart-failure-terminal-heart-failure/2024-10-16T16:38:59+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/points-of-attention-after-heart-transplantation/2024-10-18T14:44:27+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/considerations-when-following-up-a-patient-with-an-lvad/2024-10-18T14:54:44+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/what-to-do-in-case-of-heart-rhythm-disorders/2024-10-18T15:00:47+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/hyperkalemia/2024-11-05T17:13:43+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/progressive-renal-insufficiency/2024-11-05T17:05:05+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/iron-deficiency/2024-10-18T15:48:35+02:00https://www.heartfailure-pathway.elicla-dev.be/en/general/2024-10-01T15:35:46+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-at-discharge/2024-10-02T11:32:24+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/prognostic-benefits-of-the-treatments-of-heart-failure/2024-10-02T13:49:07+02:00https://www.heartfailure-pathway.elicla-dev.be/en/strong-hf-study/2024-10-11T14:18:04+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/what-to-do-in-case-of-clinical-signs-of-cardiac-decompensation/2024-10-16T15:44:52+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/the-impact-of-heart-failure/2024-10-11T13:36:51+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-for-nurses-in-an-admitted-patient-with-heart-failure/2024-10-09T11:10:21+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/the-heart-failure-nurse/2024-10-09T11:19:00+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/hospitalization-of-a-patient-with-heart-failure-in-a-non-cardiology-department/2024-10-09T13:35:56+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/hospitalization-for-heart-failure/2024-10-09T13:29:29+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/telemonitoring-en/2024-10-09T14:12:25+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-for-physiotherapists-in-an-admitted-patient-with-heart-failure/2024-10-09T11:52:31+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-for-dietitians-in-an-admitted-patient-with-heart-failure/2024-10-09T11:55:50+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-for-social-assistants-in-an-admitted-patient-with-heart-failure/2024-10-09T12:00:17+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/tasks-of-the-hospital-pharmacy-in-an-admitted-patient-with-heart-failure/2024-10-09T13:17:31+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-attention-for-psychologists-or-psychiatrists-in-an-admitted-patient-with-heart-failure/2024-10-09T15:39:32+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/follow-up-of-a-heart-failure-patient/2024-10-09T13:43:55+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/role-of-the-general-practitioner/2024-10-09T14:14:47+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/the-heart-failure-clinic/2024-10-09T14:01:24+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/what-to-do-in-case-of-hypotension/2024-10-16T15:41:57+02:00https://www.heartfailure-pathway.elicla-dev.be/en/tasks-and-points-of-attention-for-the-pharmacy-during-the-outpatient-follow-up-of-a-heart-failure-patient/2024-10-09T14:33:49+02:00https://www.heartfailure-pathway.elicla-dev.be/en/tasks-and-points-of-interest-for-nurses-during-outpatient-follow-up-of-a-patient-with-heart-failure/2024-10-09T14:47:43+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/tasks-and-points-of-attention-of-physiotherapists-during-the-outpatient-follow-up-of-a-heart-failure-patient/2024-10-09T14:56:38+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/tasks-and-points-of-attention-of-dietitians-during-the-outpatient-follow-up-of-a-heart-failure-patient/2024-10-09T15:33:23+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-follow-up/points-of-interest-of-psychologists-and-psychiatrists-during-the-outpatient-follow-up-of-a-heart-failure-patient/2024-10-09T15:38:03+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/heart-failure-in-belgium-in-numbers/2024-10-11T13:00:12+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/the-heart-failure-care-pathway/2024-10-11T13:24:30+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/what-is-heart-failure/2024-10-11T13:48:53+02:00https://www.heartfailure-pathway.elicla-dev.be/en/advor-trial/2024-10-11T14:12:47+02:00https://www.heartfailure-pathway.elicla-dev.be/en/contact-us/2024-10-11T14:09:22+02:00https://www.heartfailure-pathway.elicla-dev.be/en/informations/2024-10-11T14:39:08+02:00https://www.heartfailure-pathway.elicla-dev.be/en/mission-statement-and-terms-of-use/2024-10-11T14:53:48+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/what-to-do-if-there-are-signs-of-dehydration/2024-10-16T16:33:45+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/points-of-attention-for-patients-with-an-implantable-device-pacemakers-icd-crt/2024-10-18T15:28:47+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/anemia/2024-10-18T16:24:06+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/hypokaliemie/2024-11-05T17:24:44+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/hypernatremia/2024-11-06T13:32:50+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/hyponatremia/2024-11-06T13:33:24+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/thyroid-disease-when-using-amiodarone/2024-11-06T13:33:47+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/coronary-artery-disease/2024-11-06T13:34:51+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/valvular-disease/2024-11-06T13:43:28+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/cardio-oncology-and-therapy-with-risk-of-cardiotoxicity/2024-11-06T13:58:51+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/diabetes-mellitus/2024-11-06T14:19:36+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/hyperuricemia-and-gout/2024-11-06T14:22:18+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/erectile-dysfunction/2024-11-06T14:24:27+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/sleep-disorders-and-sleep-apnea/2024-11-06T14:27:50+01:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/depression/2024-11-06T14:32:07+01:00https://www.heartfailure-pathway.elicla-dev.be/en/cookie-policy-eu/2024-11-12T14:52:42+01:00https://www.heartfailure-pathway.elicla-dev.be/en/ttr-stabilizers/2025-06-03T15:00:38+02:00https://www.heartfailure-pathway.elicla-dev.be/en/ttr-gene-silencersvutrisiran-amvuttra/2025-06-03T15:10:03+02:00https://www.heartfailure-pathway.elicla-dev.be/en/myosin-inhibitormavacamten-camzyos/2025-06-03T15:18:19+02:00https://www.heartfailure-pathway.elicla-dev.be/en/patient-recommendations-overview/2025-06-03T15:29:52+02:00https://www.heartfailure-pathway.elicla-dev.be/en/what-to-do-in-case-of-illness-or-surgery/2025-06-04T14:26:19+02:00https://www.heartfailure-pathway.elicla-dev.be/en/prevention-of-heart-failure/2025-06-04T14:32:17+02:00https://www.heartfailure-pathway.elicla-dev.be/en/multidisciplinary-care-pathway-for-heart-failure-overview/2025-06-04T14:55:29+02:00https://www.heartfailure-pathway.elicla-dev.be/en/the-treatment-of-heart-failure/interventions-what-to-do-if/arterial-hypertension/2025-07-29T10:58:54+02:00